GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Sabra Health Care REIT Inc (NAS:SBRA) » Definitions » EBITDA

Sabra Health Care REIT (Sabra Health Care REIT) EBITDA : $311.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sabra Health Care REIT EBITDA?

Sabra Health Care REIT's EBITDA for the three months ended in Dec. 2023 was $88.5 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $311.8 Mil.

During the past 12 months, the average EBITDA Growth Rate of Sabra Health Care REIT was 43.80% per year. During the past 3 years, the average EBITDA Growth Rate was -9.20% per year. During the past 5 years, the average EBITDA Growth Rate was -15.90% per year. During the past 10 years, the average EBITDA Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Sabra Health Care REIT was 45.30% per year. The lowest was -35.50% per year. And the median was 23.45% per year.

Sabra Health Care REIT's EBITDA per Share for the three months ended in Dec. 2023 was $0.37. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.34.

During the past 12 months, the average EBITDA per Share Growth Rate of Sabra Health Care REIT was 42.60% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -12.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -20.50% per year. During the past 10 years, the average EBITDA per Share Growth Rate was -12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Sabra Health Care REIT was 12.90% per year. The lowest was -39.80% per year. And the median was -5.15% per year.


Sabra Health Care REIT EBITDA Historical Data

The historical data trend for Sabra Health Care REIT's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sabra Health Care REIT EBITDA Chart

Sabra Health Care REIT Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 380.58 416.29 166.21 216.89 311.81

Sabra Health Care REIT Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.00 72.61 93.98 56.75 88.47

Competitive Comparison of Sabra Health Care REIT's EBITDA

For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sabra Health Care REIT's EV-to-EBITDA Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Sabra Health Care REIT's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sabra Health Care REIT's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sabra Health Care REIT's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Sabra Health Care REIT's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, Sabra Health Care REIT's EBITDA was $311.8 Mil.

Sabra Health Care REIT's EBITDA for the quarter that ended in Dec. 2023 is calculated as

Sabra Health Care REIT's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2023, Sabra Health Care REIT's EBITDA was $88.5 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $311.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Sabra Health Care REIT  (NAS:SBRA) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Sabra Health Care REIT EBITDA Related Terms

Thank you for viewing the detailed overview of Sabra Health Care REIT's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sabra Health Care REIT (Sabra Health Care REIT) Business Description

Traded in Other Exchanges
Address
18500 Von Karman Avenue, Suite 550, Irvine, CA, USA, 92612
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities. The company considers merger and acquisition investment as a component of its operational growth strategy. Sabra works with existing operators to identify strategic development opportunities.
Executives
Michael Lourenco Costa officer: Executive VP & CAO 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Catherine Cusack director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Andrews Harold W. Jr. officer: Executive VP, CFO & Secretary C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Michael J Foster director 36 GROVE STREET, NEW CANAAN CT 06840
Ann Kono director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Porter Clifton J Ii director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Robert A. Ettl director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Richard K Matros director, officer: CEO and President
Raymond J Lewis director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Lynne S Katzmann director 18500 VON KARMAN AVENUE,SUITE 550, IRVINE CA 92612
Milton J Walters director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Ronald G Geary director 10140 LINN STATION RD, LOUISVILLE KY 40223-3813
Jeffrey A. Malehorn director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Talya Nevo-hacohen officer: Executive VP, CIO & Treasurer C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305